Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Mulks; Martha H.
Address:
Williamston, MI
No. of patents:
8
Patents:












Patent Number Title Of Patent Date Issued
6656477 43 Kd protein vaccine and method for the production thereof December 2, 2003
A protein derivable from Actinobacillus pleuropneumoniae (APP) having a molecular size ranging between 43 Kd on SDS PAGE is described. The protein is soluble on sodium lauryl sarcosinate (SLS) and not heat modifiable. The protein can also be derived by recombinant methods. The protein in
6410021 Vaccines of pasteurellaceae mutants and vaccination method June 25, 2002
A live vaccine of recombinant mutants of a member of the family Pasteurellaceae lacking a rib gene necessary for production of riboflavin as well as a method of vaccination therewith is described. The vaccine is effective against members of the family Pasteurellaceae.
6022728 Method for producing a bacterial vaccine and novel vaccines produced thereby February 8, 2000
A new method for the preparation of a whole cell bacterial vaccine for improved protection against bacterial pathogens, particularly against those pathogens which have multiple antigenic serotypes is described. The method particularly involves disruption of the whole cells using a French
5925354 Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae July 20, 1999
Described is a vaccine against Actinobacillus pleuropneumoniae (APP) comprising genetically defined biochemically attenuated mutant of APP that requires riboflavin and is attenuated in vivo.
5911996 43 Kd protein vaccine and method for the production thereof June 15, 1999
A protein derivable from Actinobacillus pleuropneumoniae (APP) having a molecular size ranging between 43 Kd on SDS PAGE is described. The protein is soluble on sodium lauryl sarcosinate (SLS) and not heat modifiable. The protein can also be derived by recombinant methods. The protein in
5879952 43 Kd protein vaccine and method for the production thereof March 9, 1999
A protein derivable from Actinobacillus pleuropneumoniae (APP) having a molecular size ranging between 43 Kd on SDS PAGE is described. The protein is soluble on sodium lauryl sarcosinate (SLS) and not heat modifiable. The protein can also be derived by recombinant methods. The protein in
5688682 Method for producing a bacterial vaccine and novel vaccines produced thereby November 18, 1997
A new method for the preparation of a whole cell bacterial vaccine for improved protection against bacterial pathogens, particularly against those pathogens which have multiple antigenic serotypes is described. The method particularly involves selective sonication of the whole cells of
5543304 43 Kd protein vaccine and method for the production thereof August 6, 1996
A protein derivable from Actinobacillus pleuropneumoniae (APP) having a molecular size ranging between 43 Kd on SDS PAGE is described. The protein is soluble on sodium lauryl sarcosinate (SLS) and not heat modifiable. The protein can also be derived by recombinant methods. The protein in










 
 
  Recently Added Patents
Pyroelectric detector, pyroelectric detection device, and electronic instrument
Antenna device and wireless communication apparatus
Method and system for providing status of a machine
Light emitting device
Mobile terminal and controlling method thereof
Cooler
Contact sensor, driver device, and care bed
  Randomly Featured Patents
Outboard motor steering system
System and user interface for producing acoustic response predictions via a communications network
Motor vehicle park brake cable and eyelet
Image transmission method, computer-readable image transmission program, recording medium, and image transmission apparatus
Divider and mixer circuit having the same
Method for processing solid or molten materials
Control of solid-state image sensor
Safety debris catcher
Combined microwave oven and grill oven with automated cooking _performance
Control system for hybrid vehicle